ArticleFrontiers in dental medicine2026
Changes in transverse dimensions in growing patients treated with AMCOP® and electromyographic assessment with Teethan®.
Article in Frontiers in dental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To retrospectively evaluate transverse maxillary changes and neuromuscular balance in growing patients treated with AMCOP® elastodontic appliances by combining three-dimensional digital model analysis and surface electromyography (sEMG). Materials and methods: This monocentric retrospective case series included 12 children (8 females, 4 males; aged 4-7 years) treated for transverse maxillary deficiency with AMCOP® Integral or Class III (TC) devices for 10-18 months. Transverse widths were measured on digital models (Deltadent®) at baseline (T0) and post-treatment (T1) at the intercanine, inter-second deciduous molar (inter-5), and intermediate or first molar regions when erupted. Neuromuscular function was assessed using surface electromyography (Teethan®), evaluating symmetry indices (POC TA/MM), barycenter (BAR), torsion (TORS), asymmetry (ASIM), and impact index (IMP). Results: All patients showed transverse maxillary expansion. Intercanine increases ranged from +0.5 to +4.9 mm, inter-5 from +1.15 to +6.26 mm, and intermolar measurements (available in 6 patients) from +1.83 to +4.87 mm. sEMG recordings demonstrated improvement in neuromuscular coordination in most cases, including normalization or improvement of BAR, reduction of TORS and ASIM values, and enhancement of IMP toward physiological ranges. No adverse events were recorded. Conclusions: Within the limitations of this retrospective case series, AMCOP® elastodontic therapy was associated with clinically relevant transverse maxillary widening and favorable neuromuscular rebalancing. These preliminary findings support elastodontic functional interception as a conservative approach for early transverse deficiency, although controlled comparative studies are required to confirm treatment efficacy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.